Nociceptin/Orphanin FQ (N/OFQ) conjugated to ATTO594: a novel fluorescent probe for the N/OFQ (NOP) receptor

被引:16
作者
Bird, M. F. [1 ]
Guerrini, R. [2 ,3 ]
Willets, J. M. [4 ]
Thompson, J. P. [1 ]
Calo, G. [5 ,6 ]
Lambert, D. G. [1 ]
机构
[1] Univ Leicester, Dept Cardiovasc Sci Anaesthesia Crit Care & Pain, Leicester Royal Infirm, Leicester, Leics, England
[2] Univ Ferrara, Dept Chem & Pharmaceut Sci, Ferrara, Italy
[3] Univ Ferrara, LTTA, Ferrara, Italy
[4] Univ Leicester, Dept Mol & Cell Biol, Leicester, Leics, England
[5] Univ Ferrara, Dept Med Sci, Sect Pharmacol, Ferrara, Italy
[6] Univ Ferrara, Natl Inst Neurosci, Ferrara, Italy
基金
英国生物技术与生命科学研究理事会;
关键词
COMMERCIAL ANTIBODIES; MESSENGER-RNA; EXPRESSION; SPECIFICITY; BINDING; INTERNALIZATION; DESENSITIZATION; ANTAGONIST; MECHANISMS; DENSITY;
D O I
10.1111/bph.14504
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and Purpose Experimental Approach The nociceptin/orphanin FQ (N/OFQ) receptor (NOP) is a member of the opioid receptor family and is involved in a number of physiological responses, pain and immune regulation as examples. In this study, we conjugated a red fluorophore-ATTO594 to the peptide ligand N/OFQ (N/OFQ(ATTO594)) for the NOP receptor and explored NOP receptor function at high (in recombinant systems) and low (on immune cells) expression. We assessed N/OFQ(ATTO594) receptor binding, selectivity and functional activity in recombinant (CHO) cell lines. Live cell N/OFQ(ATTO594) binding was measured in (i) HEK cells expressing NOP and NOPGFP receptors, (ii) CHO cells expressing the hNOPG alpha qi5 chimera (to force coupling to measurable Ca2+ responses) and (iii) freshly isolated human polymorphonuclear cells (PMN). Key Results Conclusions and Implications N/OFQ(ATTO594) bound to NOP receptor with nM affinity and high selectivity. N/OFQ(ATTO594) activated NOP receptor by reducing cAMP formation and increasing Ca2+ levels in CHOhNOPG alpha qi5 cells. N/OFQ(ATTO594) was also able to visualize NOP receptors at low expression levels on PMN cells. In NOP-GFP-tagged receptors, N/OFQ(ATTO594) was used in a FRET protocol where GFP emission activated ATTO, visualizing ligand-receptor interaction. When the NOPGFP receptor is activated by N/OFQ(ATTO594), movement of ligand and receptor from the cell surface to the cytosol can be measured. In the absence of validated NOP receptor antibodies and issues surrounding the use of radiolabels (especially in low expression systems), these data indicate the utility of N/OFQ(ATTO594) to study a wide range of N/OFQ-driven cellular responses.
引用
收藏
页码:4496 / 4506
页数:11
相关论文
共 51 条
[1]  
Ahmadi F, 2014, IRAN J PHARM RES, V13, P79
[2]   Evidence for nociceptin/orphanin FQ (NOP) but not μ (MOP), δ (DOP) or κ (KOP) opioid receptor mRNA in whole human blood [J].
Al-Hashimi, M. ;
McDonald, J. ;
Thompson, J. P. ;
Lambert, D. G. .
BRITISH JOURNAL OF ANAESTHESIA, 2016, 116 (03) :423-429
[3]   Opioids and immune modulation: more questions than answers [J].
Al-Hashimi, M. ;
Scott, S. W. M. ;
Thompson, J. P. ;
Lambert, D. G. .
BRITISH JOURNAL OF ANAESTHESIA, 2013, 111 (01) :80-88
[4]   THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors [J].
Alexander, Stephen P. H. ;
Christopoulos, Arthur ;
Davenport, Anthony P. ;
Kelly, Eamonn ;
Marrion, Neil V. ;
Peters, John A. ;
Faccenda, Elena ;
Harding, Simon D. ;
Pawson, Adam J. ;
Sharman, Joanna L. ;
Southan, Christopher ;
Davies, Jamie A. .
BRITISH JOURNAL OF PHARMACOLOGY, 2017, 174 :S17-S129
[5]   Binding and internalization of fluorescent opioid peptide conjugates in living cells [J].
Arttamangkul, S ;
Alvarez-Maubecin, V ;
Thomas, G ;
Williams, JT ;
Grandy, DK .
MOLECULAR PHARMACOLOGY, 2000, 58 (06) :1570-1580
[6]   Effects of receptor density on Nociceptin/OrphaninFQ peptide receptor desensitisation: studies using the ecdysone inducible expression system [J].
Barnes, T. A. ;
McDonald, J. ;
Rowbotham, D. J. ;
Duarte, T. L. ;
Lambert, D. G. .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2007, 376 (03) :217-225
[7]   Nonspecific CXCR7 antibodies [J].
Berahovich, Robert D. ;
Penfold, Mark E. T. ;
Schall, Thomas J. .
IMMUNOLOGY LETTERS, 2010, 133 (02) :112-114
[8]   Development and characterisation of novel fentanyl-delta opioid receptor antagonist based bivalent ligands [J].
Bird, M. F. ;
Vardanyan, R. S. ;
Hruby, V. J. ;
Calo, G. ;
Guerrini, R. ;
Salvadori, S. ;
Trapella, C. ;
McDonald, J. ;
Rowbotham, D. J. ;
Lambert, D. G. .
BRITISH JOURNAL OF ANAESTHESIA, 2015, 114 (04) :646-656
[9]   Characterisation of the Novel Mixed Mu-NOP Peptide Ligand Dermorphin-N/OFQ (DeNo) [J].
Bird, Mark F. ;
Cerlesi, Maria Camilla ;
Brown, Mark ;
Malfacini, Davide ;
Vezzi, Vanessa ;
Molinari, Paola ;
Micheli, Laura ;
Mannelli, Lorenzo Di Cesare ;
Ghelardini, Carla ;
Guerrini, Remo ;
Calo, Girolamo ;
Lambert, David G. .
PLOS ONE, 2016, 11 (06)
[10]   Loss of human Greatwall results in G2 arrest and multiple mitotic defects due to deregulation of the cyclin B-Cdc2/PP2A balance [J].
Burgess, Andrew ;
Vigneron, Suzanne ;
Brioudes, Estelle ;
Labbe, Jean-Claude ;
Lorca, Thierry ;
Castro, Anna .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (28) :12564-12569